Fentermin

Fentermin
IUPAC ime
	2-metil-1-fenilpropan-2-amin
Klinički podaci
Prodajno ime	Adipex-P, Duromine, Fastin, Inoamin
Drugs.com	Monografija
Način primene	Oralno
Farmakokinetički podaci
Poluvreme eliminacije	16 do 31 sati
Identifikatori
CAS broj	122-09-8
ATC kod	A08AA01 (WHO)
PubChem	CID 4771
DrugBank	DB00191
ChemSpider	4607
KEGG	C07438
ChEMBL	CHEMBL8080
Hemijski podaci
Formula	C10H15N
Molarna masa	149.2328
	SMILES CC(C)(N)CC1=CC=CC=C1; ;
	InChI InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3 ; Key:DHHVAGZRUROJKS-UHFFFAOYSA-N ;
Fizički podaci
Tačka topljenja	205 °C (401 °F)

Fentermin je stimulans centralnog nervnog sistema i simpatomimetik sa dejstvom i primenom sličnom sa dekstroamfetaminu. On je korišten za tretiranje gojaznosti. Naka od tržišnih imena su: -[Adipex-P]- i Suprenza. Fentermin je takođe dostupan u kombinacijama sa drugim lekovima, kao što je Qsymia.^[1]^[2]^[3]^[4]

Reference

^ Bray GA: A concise review on the therapeutics of obesity. Nutrition. 2000 Oct;16(10):953-60. PMID 11054601
^ Nelson DL, Gehlert DR: Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine. 2006 Feb;29(1):49-60. PMID 16622292
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMID 21059682.
^ Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (Nucleic Acids Res) (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. 36 (Database issue): D901—6. PMID 18048412.

Spoljašnje veze

Phentermine

Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).

[1] Bray GA: A concise review on the therapeutics of obesity. Nutrition. 2000 Oct;16(10):953-60. PMID 11054601

[2] Nelson DL, Gehlert DR: Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine. 2006 Feb;29(1):49-60. PMID 16622292

[3] Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMID 21059682.

[4] Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (Nucleic Acids Res) (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. 36 (Database issue): D901—6. PMID 18048412.

[1]

[2]

[3]

[4]